Abstract
TechNavio's analysts forecast the Global Veterinary Vaccines market to grow at
a CAGR of 12.5 percent over the period 2011-2015. One of the key factors
contributing to this market growth is the increase in prevalence of zoonotic
diseases in humans. The Global Veterinary Vaccines market has also been
witnessing a rise in contract manufacturing activities. However, the emergence
of vaccine-resistant viruses could pose a challenge to the growth of this
market.
TechNavio's report, the Global Veterinary Vaccines Market 2011-2015, has been
prepared based on an in-depth analysis of the market with inputs from industry
experts. The report covers the Americas, and the EMEA and APAC regions; it
also covers the Livestock vaccines and Companion vaccines landscape and its
growth prospects in the coming years. The report also includes a discussion of
the key vendors operating in this market.
Key vendors dominating this market space include Eli Lilly and Co., Merck &
Co. Inc., Pfizer Inc., and Sanofi S.A.
Other vendors mentioned in the report: AVANT Immunotherapeutics Inc., Embrex
Inc., Bayer AG, Boehringer Ingelheim GmbH, Heska Corp., Imugene Ltd., Indian
Immunologicals Ltd., Intervet International B.V., Lohmann Animal Health GmbH &
Co. KG, Novartis AG, Protein Sciences Corp., Schering-Plough Corp., and Vibrac
AH Inc.
Key questions answered in this report:
- What will the market size be in 2015 and at what rate will it grow?
- What key trends is this market subject to?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the opportunities and threats faced by each of these key vendors?
- What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of analyst time when you purchase this report.
Details provided within the report.
Table of Contents
01. Executive Summary
02. Introduction
03. Market Coverage
- Market Overview
- Key Products
04. Market Landscape
- Global Veterinary Vaccines Market
- Overall Market Size
- Market Segmentation by Vaccine Category
- Market Segmentation by Animal Category
- 04.1. Segmentation of Global Livestock Vaccines Market
- 04.2. Segmentation of Global Companion Vaccines Market
05. Geographical Segmentation
06. Key Leading Countries
07. Vendor Landscape
- Vendor Ranking
- Product Portfolio Matrix
- Global Animal Health Products Market
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Key Vendor Analysis
- 14.1. Pfizer Inc.
- Business Overview
- SWOT Analysis
- 14.2. Merck and Co. Inc.
- Business Overview
- SWOT Analysis
- 14.3. Sanofi S.A.
- Business Overview
- SWOT Analysis
- 14.4. Eli Lilly and Co.
- Business Overview
- SWOT Analysis
15. Other Reports in this Series
List of Exhibits:
- Exhibit 1: Global Veterinary Vaccines Market by Product Segmentation
- Exhibit 2: Global Veterinary Vaccines Market 2011-2015 (US$ billion)
- Exhibit 3: Global Veterinary Vaccines Market Segmentation by Vaccine
Category 2011
- Exhibit 4: Global Veterinary Vaccines Market Segmentation by Animal
Category 2011
- Exhibit 5: Global Livestock Vaccines Market Segmentation by Animal
Category 2011
- Exhibit 6: Global Companion Vaccines Market Segmentation By Animal
Category 2011
- Exhibit 7: Global Veterinary Vaccines Market by Geographical Segmentation
2011
- Exhibit 8: Global Animal Health Products Market by Vendor Segmentation 2011
Global Veterinary Vaccines Market 2011-2015 published by Infiniti Research Limited (Technavio) in July 30, 2012. This report consists of Pages: 41 and the price starts from US $ 1500.